Literature DB >> 11241887

Visual electrophysiological responses in persons with type 1 diabetes.

V Parisi1, L Uccioli.   

Abstract

Persons with type 1 diabetes show electrophysiological abnormalities of the visual system which are revealed by methods such as flash electroretinogram (FERG), oscillatory potentials (OPs), pattern electroretinogram (PERG), focal electroretinogram (focal ERG), visual evoked potentials (VEP) in basal condition and after photostress. This review reports the changes in electrophysiological responses of the different structures composing the visual system observed in persons with type 1 diabetes before the development of the overt clinical retinopathy. In persons with type 1 diabetes without retinopathy (IDD), the earlier abnormal electrophysiological responses are recorded from the innermost retinal layers and postretinal visual pathways, as suggested by impaired PERGs and delayed retinocortical time (RCT). These are observed in IDD persons with a disease duration shorter than 6 months. Further electrophysiological changes are recorded from the macula (abnormal focal ERG and VEP after photostress) in IDD persons with disease duration greater than 1 year. Additional electrophysiological changes are recorded from the middle and outer retinal layers (impaired FERG and OPs) in IDD persons with a disease duration greater than 10 years. All the electrophysiological tests show a greater degree of abnormal responses in persons with type 1 diabetes when a background retinopathy is present. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11241887     DOI: 10.1002/dmrr.177

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  42 in total

1.  Test-retest repeatability of the pattern electroretinogram and flicker electroretinogram.

Authors:  Arthur F Resende; Carina T Sanvicente; Hamoon Eshraghi; Alberto Garcia; Kassandra Pickel; Qiang Zhang; Michael Waisbourd; L Jay Katz
Journal:  Doc Ophthalmol       Date:  2019-07-16       Impact factor: 2.379

2.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

3.  Correlation between diabetic lower-extremity arterial disease and diabetic neuropathy in patients with type II diabetes: an exploratory study.

Authors:  Peng Sun; Jianchao Guo; Na Xu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Reproducibility of Fixed-luminance and Multi-luminance Flicker Electroretinography in Patients With Diabetic Retinopathy Using an Office-based Testing Paradigm.

Authors:  John J Wroblewski; Christa McChancy; Kassandra Pickel; Hunter Buterbaugh; Tyler Wieland; Alberto Gonzalez
Journal:  J Diabetes Sci Technol       Date:  2019-10-22

5.  The effects of early diabetes on inner retinal neurons.

Authors:  Erika D Eggers; Teresia A Carreon
Journal:  Vis Neurosci       Date:  2020-09-16       Impact factor: 3.241

6.  Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.

Authors:  Yan-Fang Si; Jun Wang; Juan Guan; Li Zhou; Yu Sheng; Juan Zhao
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

7.  Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.

Authors:  Jan J Blom; Thomas J Giove; Tara L Favazza; James D Akula; William D Eldred
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-12

8.  The effect of combined renal and pancreatic transplantation on diabetic retinopathy.

Authors:  Kate E Shipman; Chetan K Patel
Journal:  Clin Ophthalmol       Date:  2009-10-19

9.  Increased neuronal nitric oxide synthase activity in retinal neurons in early diabetic retinopathy.

Authors:  Thomas J Giove; Monika M Deshpande; Christine S Gagen; William D Eldred
Journal:  Mol Vis       Date:  2009-11-09       Impact factor: 2.367

10.  Diabetes changes the levels of ionotropic glutamate receptors in the rat retina.

Authors:  Ana R Santiago; Joana M Gaspar; Filipa I Baptista; Armando J Cristóvão; Paulo F Santos; Willem Kamphuis; António F Ambrósio
Journal:  Mol Vis       Date:  2009-08-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.